Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andree Daigneault, Dr.
Clinique des Maladies Affectives, Montreal
Study Director - Angelo B Miralha da Cunha, Dr.
Santa Maria, Brazil
Study Director - Ayal Schaffer, Dr.
Sunnybrook Health Sciences Centre, Toronto, Ont.
Study Director - Benny Lafer, Dr.
Instituto de Psiquiatria do Hospital das Clínicas, Sao Paulo, Brazil
Study Director - Claire O'Donovan, Dr.
Mental Health Services, Halifax, NS
Study Director - Flavio Kapczinski, Dr.
Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
Study Director - Hubert Wong, Dr.
University of British Columbia
Study Director - Joao Quevedo, Dr.
Casa de Saude do Rio Maina Ltda, Criciuma, Brazil
Study Director - Lakshmi N Yatham, Dr.
University of British Columbia
Principal Investigator - Pablo Cervantes, Dr.
Montreal General, Quebec
Study Director - Peter Silverstone, Dr.
University of Alberta
Study Director - Philippe Baruch, Dr.
Clinique des troubles de l'humeur, Quebec
Study Director - Ram Veluri, Dr.
Northern Health Research Inc., Sudbury, Ont.
Study Director - Roumen Milev, Dr.
Providence Continuing Care, Kingston, Ont.
Study Director - Sagar Parikh, Dr.
Centre for Addiction and Mental Health, Toronto, Ont.
Study Director - Serge Beaulieu, Dr.
McGill University, Montreal
Study Director - Verinder Sharma, Dr.
Regional Mental Health Care London, Ont.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of British Columbia
Vancouver, British Columbia, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2003
- Primary completion
- 31 Aug 2011
- Completion
- 31 Aug 2011
- Last update posted
- 20 Nov 2015
- Registered enrollment
- 159
- Registry id
- NCT01977300
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.